Πλοήγηση ανά Θέμα "venous thromboembolism"
Αποτελέσματα 21-31 από 31
-
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks
(2022)Background: During pregnancy and puerperium women are at high VTE risk. Current guidelines recommend dynamic VTE-risk assessment during pregnancy. Based on related RCOG-guidelines we constructed a digital VTE-risk assessment ... -
Prevalence of Hemorrhagic Complications in Hospitalized Patients with Pulmonary Embolism
(2022)Background: The prevalence of anticoagulant therapy-associated hemorrhagic complications in hospitalized patients with pulmonary embolism (PE) has been scarcely investigated. Aim: To evaluate the prevalence of hemorrhages ... -
Real world data regarding the management of cancer-associated thrombosis
(2020)PURPOSE OF REVIEW: Patients with cancer are at high risk for thrombotic events, mainly deep vein thrombosis and pulmonary embolism. Low-molecular-weight heparins (LMWHs) and direct oral anticoagulants (DOACs) are among the ... -
Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode
(2018)[No abstract available] -
The risk of venous thromboembolic events in patients with inflammatory bowel disease: A systematic review and meta-analysis
(2021)Background Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disorder of the gastrointestinal tract that has been associated with increased risk of ... -
The role of direct oral anticoagulants in cancer-associated thrombosis according to the current literature
(2021)Venous thromboembolism (VTE) is a common complication among patients suffering from malignancies, leading to an increased mortality rate. Novel randomized trials have added valuable information regarding cancer-associated ... -
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19
(2022)BACKGROUND: Venous thromboembolism (VTE) contributes significantly to COVID-19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels of soluble urokinase plasminogen ... -
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports
(2022)Background: Venous Thromboembolism (VTE) is common among patients with severe Coronavirus Disease 2019 (COVID-19). Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the ... -
Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study – The SeVEN EXTension study
(2021)Background: To assess the treatment of superficial vein thrombosis (SVT) with intermediate dose of tinzaparin in a setting of real world practice. Methods: Prospective observational study of consecutive patients treated ... -
Upadacitinib tartrate in rheumatoid arthritis
(2020)does not achieve low disease activity or remission despite the use of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and/or biological DMARDs (bDMARDs). The Janus kinase (JAK) inhibitors are the ... -
Venous thromboembolic disease in chronic inflammatory lung diseases: Knowns and unknowns
(2021)Persistent inflammation within the respiratory tract underlies the pathogenesis of numerous chronic pulmonary diseases. There is evidence supporting that chronic lung diseases are associated with a higher risk of venous ...